Non-alcoholic fatty liver disease (NAFLD)
Chronic liver diseases (CLDs)
Sarcopenic obesity (Sa-O)
NAFLD fibrosis score (NFS)
Non-alcoholic fatty liver disease (NAFLD) has been most common liver disease, which is prevalent for 25% worldwide. NAFLD with BMI <25 (non-obese NAFLD) is not a rare disease than expected. The prevalence of non-obese NAFLD for general population is 5.1% from 23 studies. NAFLD incidence among non-obese people was 24.6 per 1000 person-years. Currently, prevalence of non-NAFLD among NAFLD group in Europe vs East Asia are 50% vs 38%. For retrospective cohort study for NAFLD, the risk of T2DM vs hypertension was 11.7 vs 7.99, respectively, and hazard ratio (HR) was 1.09 for older age and 2.87 for T2DM.
Journal of Diabetes, Obesity & Metabolism
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License(https://creativecommons.org/licenses/by-nc-sa/4.0/).
jdom_4_1_e106.pdf 138 KB